You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

deferasirox FCT

Showing 1 - 25 of 108
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Transfusion-dependent Thalassemia, Non-transfusion-dependent Thalassemia Trial in Worldwide (Deferasirox dispersable tablet

Completed
Has Results
  • Transfusion-dependent Thalassemia
  • Non-transfusion-dependent Thalassemia
  • Deferasirox dispersable tablet (DT)
  • Deferasirox film coated tablet (FCT)
  • Alexandria, Egypt
  • +16 more
Sep 6, 2021

Chronic Iron Overload Trial in Austria, Greece, Italy (Deferasirox)

Completed
Has Results
  • Chronic Iron Overload
  • Vienna, Austria
  • +13 more
Feb 18, 2020

MDS Trial in Italy (Deferasirox)

Unknown status
  • Myelodysplastic Syndromes
  • Firenze, FI, Italy
  • +9 more
Jul 15, 2019

Decreasing Destructive Behavior, Increasing Functional Communicative Behavior Trial in New Brunswick, Somerset (Traditional

Not yet recruiting
  • Decreasing Destructive Behavior
  • Increasing Functional Communicative Behavior
  • Traditional Schedule Thinning
  • +2 more
  • New Brunswick, New Jersey
  • +1 more
Mar 29, 2023

Problem Behavior, Intellectual Disability, Developmental Disorder Trial (Functional communication training)

Recruiting
  • Problem Behavior
  • +2 more
  • Functional communication training
  • Bowling Green, Kentucky
    Western Kentucky University
Dec 14, 2022

Aggression, Self-injurious Behavior Trial in Somerset (Trad FCT, Mult FCT, Mult FCT + Stimulus Fading)

Recruiting
  • Aggression
  • Self-injurious Behavior
  • Trad FCT
  • +2 more
  • Somerset, New Jersey
    Children's Specialized Hospital - Rutgers University Center for
Aug 22, 2022

Biomechanical Parameters of Human Movement Based on Disability

Recruiting
  • Disability
  • Exposure to disability
  • Porto, Portugal
    Center for Rehabilitation Research, School of Health, Polytechni
Nov 3, 2022

Coronary Artery Disease (CAD) Trial in Worldwide (Evolocumab, Placebo, Statin therapy)

Completed
Has Results
  • Coronary Artery Disease (CAD)
  • Los Angeles, California
  • +32 more
Apr 7, 2022

Problem Behavior, Aggression, Self Injury Trial in Somerset (Extinction-only condition, Rate-drop condition, Rate-hold

Recruiting
  • Problem Behavior
  • +2 more
  • Extinction-only condition
  • +7 more
  • Somerset, New Jersey
    Children's Specialized Hospital-Rutgers University Center for Au
Jun 21, 2023

Telerehabilitation Trial (Training Intervention and Program of Support (TIPS) for fostering the adoption of family-centred

Not yet recruiting
  • Telerehabilitation
  • Training Intervention and Program of Support (TIPS) for fostering the adoption of family-centred telehealth interventions in pediatric rehabilitation
  • (no location specified)
Apr 2, 2022

Cerebral Palsy Trial in Ottawa (Robotic Gait Training, Functional Clinical Therapy)

Recruiting
  • Cerebral Palsy
  • Robotic Gait Training
  • Functional Clinical Therapy
  • Ottawa, Ontario, Canada
    Children's Hospital of Eastern Ontario
May 12, 2022

Sickle Cell Disease Trial in Amsterdam (Deferasirox 360 MG)

Recruiting
  • Sickle Cell Disease
  • Deferasirox 360 MG
  • Amsterdam, Meibergdreef 9, Netherlands
    Amsterdan UMC location AMC
May 23, 2022

Behavior Problem, Mental Disorder, Emotional Problem Trial in Charlotte, Elkin (Family Centered Treatment, Level II or Level III

Recruiting
  • Behavior Problem
  • +2 more
  • Family Centered Treatment
  • Level II or Level III Out of Home Placement
  • Charlotte, North Carolina
  • +1 more
Mar 21, 2022

Biomechanical Parameters of Human Movement Based on Disability

Recruiting
  • Disability
  • Exposure to disability
  • Porto, Portugal
    Center for Rehabilitation Research, School of Health, Polytechni
Dec 12, 2022

Cardiac Iron Overload Trial in Worldwide (Deferasirox and Deferoxamine)

Completed
Has Results
  • Cardiac Iron Overload
  • Deferasirox and Deferoxamine
  • Toronto, Ontario, Canada
  • +14 more
Jul 23, 2021

Low and Int 1-risk Myelodysplastic Syndrome Trial in Worldwide (Deferasirox DFX, DT, Erythropoietin alpha, Deferasirox DFX, FCT)

Completed
Has Results
  • Low and Int 1-risk Myelodysplastic Syndrome
  • Deferasirox DFX, DT
  • +2 more
  • Oran, Algeria
  • +29 more
Oct 4, 2018

MDS, Iron Overload Trial in Stanford, Detroit, Houston (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Iron Overload
  • Stanford, California
  • +2 more
Jun 1, 2021

Autism Trial in United States (CM-AT, PLACEBO)

Completed
Has Results
  • Autism
  • Phoenix, Arizona
  • +30 more
Sep 28, 2022

Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndrome
  • Iron Overload
  • Birmingham, Alabama
  • +47 more
Jul 21, 2021

Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))

Completed
Has Results
  • Thalassemia
  • Iron Overload
  • Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
  • Oakland, California
    CHRCO
Jul 20, 2021

Beta-thalassemia, Iron Overload Trial in Los Angeles, Oakland, Chicago (Deferasirox)

Completed
Has Results
  • Beta-thalassemia
  • Iron Overload
  • Los Angeles, California
  • +2 more
Jun 8, 2021

Transfusional Iron Overload, Iron Overload, Iron Chelation Trial (SPD602, Deferasirox)

Withdrawn
  • Transfusional Iron Overload
  • +6 more
  • (no location specified)
Jun 1, 2021

Healthy Trial in Cairo (Ekmasonid, Uceris (first dose), Uceris (second dose))

Completed
  • Healthy
  • Cairo, Egypt
    Genuine Research Center GRC
Apr 18, 2021

Hepatic Impairment Trial in Kiel (Deferasirox)

Completed
  • Hepatic Impairment
  • Kiel, Germany
    Novartis Investigative Site
Dec 6, 2020

Measures to Prevent Liver and Pancreas Complications in

Active, not recruiting
  • Iron Overload
  • Trieste, Italy
    IRCCS Burlo Garofolo
Jan 4, 2022